Mable Therapy has secured funding
Mable Therapy has raised funds from Gresham House Ventures, a growth equity investor specializing in digitally driven businesses, to further build out its proprietary technology platform, as well as invest in sales and marketing capabilities, helping take the business to its next stage of growth.
Mable Therapy is the UK’s leading digital platform for children’s speech and language therapy and counselling services. Using cutting-edge, gamified technology, Mable Therapy’s interactive platform captivates children and young people from the moment they start their session. The platform uses creative resources, games and tools to reduce anxiety and make therapy engaging and fun.
Oaklins Cavendish, based in the UK, advised Mable Therapy on its investment from Gresham House Ventures.
Talk to the deal team
Related deals
Armira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn moreOmer Engineering has completed an IPO
Omer Engineering Ltd. has successfully launched its IPO on the Tel Aviv Stock Exchange, pricing shares as part of a plan to raise approximately US$94 million at an implied pre-money valuation of around US$313 million. The offering included both newly issued shares and a secondary sale by existing shareholders, who retained a significant majority stake post-IPO. This transaction underscores strong investor interest in scaling the company’s operations and enhancing its capital.
Learn moreTriscan has joined APA and Riverarch to accelerate growth in the European aftermarket
Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.
Learn more